A variety of abnormalities in the angiogenic profile of CLL patients have been reported including elevated serum levels of certain proangiogenic cytokines and vascular endothelial growth factor (VEGF) [3, 4], whereas current belief holds that tumor cells themselves are an important source of proangiogenic factors [5]. Here, VEGFA is linked to B-cell chronic lymphocytic leukemia.